News
At 24 weeks, 41.7% of the relapsing participants and 75% of the newly diagnosed patients attained a complete response.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback